Literature DB >> 109023

The booster phenomenon in serial tuberculin testing.

N J Thompson, J L Glassroth, D E Snider, L S Farer.   

Abstract

To determine the frequency, magnitude, and causes of the booster phenomenon in tuberculin testing, a total of 1,478 employees from 10 hospitals throughout the United States received sequential intradermal tests using PPD-T. In addition, approximately 70 per cent were initially tested with PPD-G. Boosting was found in all age groups tested, but increased with age. It occurred as soon as one week after an initial tuberculin test, but rarely before that time. The boosted reactions were apparently caused either by remote tuberculous infection or recent or remote sensitization by one or more of the nontuberculous mycobacteria. In areas endemic for nontuberculous mycobacteria, they are the most likely cause of the sensitivity that may be boosted. On the basis of these findings, it is recommended that when repeated tuberculin testing is required as part of a hospital control program, a second identical tuberculin test be given one week after the first. When subsequent tests are given, this should permit separation of boosted reactions from reactions caused by new infections. Persons who do not boost when giben repeat tests at one week, but whose tuberuclin reactions change to positive after one year, should be considered to have newly acquired tuberculous infection and managed accordingly.

Entities:  

Mesh:

Year:  1979        PMID: 109023     DOI: 10.1164/arrd.1979.119.4.587

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  30 in total

1.  Diagnosis and management of tuberculosis.

Authors:  D Ahmad
Journal:  Can Fam Physician       Date:  1982-10       Impact factor: 3.275

2.  Tuberculin skin testing in US Navy and Marine Corps personnel and recruits, 1980-86.

Authors:  E R Cross; K C Hyams
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

Review 3.  Tuberculin test.

Authors:  V K Chadha
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

4.  Transmission of Mycobacterium tuberculosis in a California State Prison, 1991.

Authors:  D T Koo; R C Baron; G W Rutherford
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

5.  Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.

Authors:  Christopher C Whalen; Allan Chiunda; Sarah Zalwango; Lorna Nshuti; Edward Jones-Lopez; Alphonse Okwera; Christina Hirsch; Pierre Peters; W Henry Boom; Roy D Mugerwa
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

6.  Epidemiology of a tuberculosis outbreak in a South Carolina junior high school.

Authors:  J J Sacks; E R Brenner; D C Breeden; H M Anders; R L Parker
Journal:  Am J Public Health       Date:  1985-04       Impact factor: 9.308

7.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

8.  First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent.

Authors:  Winnie Bergstedt; Pernille N Tingskov; Birgit Thierry-Carstensen; Søren T Hoff; Henrik Aggerbeck; Vibeke O Thomsen; Peter Andersen; Aase B Andersen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

9.  Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.

Authors:  Anne M Dyrhol-Riise; Gerd Gran; Tore Wentzel-Larsen; Bjørn Blomberg; Christel Gill Haanshuus; Odd Mørkve
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

10.  Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.

Authors:  Irma Casas; Irene Latorre; Maria Esteve; Juan Ruiz-Manzano; Dora Rodriguez; Cristina Prat; Ignasi García-Olivé; Alicia Lacoma; Vicente Ausina; Jose Domínguez
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.